North America Pharmaceutical Gelatin Market

North America Pharmaceutical Gelatin Market Size (2022 to 2027)

The size of the North America Pharmaceutical Gelatin Market is estimated to be growing at a healthy CAGR from 2022 to 2027.

The North America Pharmaceutical Gelatin Market is projected to be fuelled by the increasing prevalence of Gelatin production in capsule formation and increasing awareness about the consumption of nutrition-rich food. Also, the growing demand for Gelatin capsules is due to the proliferation of chronic diseases across the region. In addition, the growing population is more prone to various chronic diseases, which is expected to contribute to the regional market growth. 

The use of gelatin as an emulsifier and counter crystallizing agent in various food-related applications is another important factor in the North American gelatin market's growth. It also finds usage in various end-use sectors, including personal care, photography, nutraceuticals, and others. In addition, its wide use in surgeries as a hemostats reagent and its coating of hard and soft-gel capsules, which makes swallowing easier and extends the product's shelf life by protecting it from environmental changes, has made it a leading pharmaceutical ingredient.

The increased preferences for bovine bone as an alternative to pig meat gelatine in the pharmaceutical industry will boost pharmaceutical gelatin market growth. The rising flexibility, strength, and consistency of several products are the beneficial factors for the market growth. In addition, an increase in nutraceuticals and pharmaceutical industries that manufacture gelatin drugs and a rise in diseases are driving the market growth.

The other factors such as safety, stability, and increased efficacy in hard capsules, soft gels capsules, absorbable hemostats, and other wide applications in the pharmaceutical industry are driving the gelatin market growth. On the other hand, the versatility and unique functional properties of gelatin pharmaceutical gelatin in pharmaceutical applications are expected to improve the market growth. 

Furthermore, gelatin's properties protect against environmental changes such as oxygen or moisture, extending the shelf life of these items. As a result, the pharmaceutical gelatin market is driven by gelatin's outstanding functional properties.

However, cultural restrictions in porcine and bovine-derived gelatine consumption and rising raw materials prices may hamper the North American pharmaceutical gelatine market. Also, the high cost of gelatin, which is heavily utilized in the outer covering of capsules, and substitute components restrain the market growth.

This research report on the North American pharmaceutical gelatin market has been segmented and sub-segmented into the following categories:

By Function:

• Stabilizers
• Thickeners        
• Gelling Agents     

By Source:

• Pig Skin
• Bovine Hides
• Bones 
• Others

By Application:

• Hard Capsules     
• Soft Capsules      
• Micro Encapsulation      
• Coating   
• Absorbable Hemostats   

By Country:

• The United States
• Canada
• Rest of North America

Geographically, the North American market holds a considerable share in the pharmaceutical gelatine market. The market growth in the region is expected to be driven by the implementation of strict regulatory mandates across the region concerning the control of Bovine Spongiform Encephalopathy. Moreover, rising awareness about nutrition fortification in food is an opportunity for the growth of this market in the future. 

The United States pharmaceutical gelatin market dominated the North American market and accounted for a significant share in 2020. Technological advances in the healthcare sector and Increasing preference for bovine bone as an alternative to pig meat gelatin in the pharmaceutical industry driving market growth. However, growing developments in the pharmaceutical and the healthcare industry the changing trends are likely to boost the growth of the pharmaceutical gelatin market in the United States.

On the other hand, the Canadian pharmaceutical gelatin market is anticipated to witness a moderate share in the coming years due to the growing incidences of chronic illnesses, the expansion of the aging population across the country, Government initiatives, and investment for better hospital facilities the market growth.  

KEY MARKET PLAYERS:

Some of the major companies dominating the market by their products and services include Rousselot, Nitta Gelatin Inc., Capsugel, Catelent Inc., Norland Products Inc, Tessenderlo Group, Sterling Gelatin, Roxlor LLC, Weishardt, and Gelita AG.